Litcius/Paper detail

Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy

Yixuan Guo, Yu Liu, Wei Wu, Daishun Ling, Qiao Zhang, Zhao Peng, Xi Hu

2021Biomaterials128 citationsDOI

Topics & Concepts

Indoleamine 2,3-dioxygenaseImmunotherapyMedicinePhotothermal therapyCancerClinical trialCancer immunotherapyImmune checkpointRadiation therapyCancer therapyImmune systemCancer researchImmunologyInternal medicineNanotechnologyBiologyMaterials scienceBiochemistryAmino acidTryptophanTryptophan and brain disordersCancer, Stress, Anesthesia, and Immune ResponsePharmacological Receptor Mechanisms and Effects
Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy | Litcius